Financials
Financial year 2025
APOTEEK VERCAMMEN from Aalst, company number BE0425132786, closed financial year 2025 with a result of € 19,647 after tax. For that financial year APOTEEK VERCAMMEN recorded a gross margin of € 171,509 and equity of € 155,720. Compared with financial year 2024, the result moved from € 21,386 to € 19,647. The company is profitable. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on June 15, 2026.
€ 155,720
▲ 14% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 19,647
▼ 8% vs 2024
Profit after tax over the fiscal year.
€ 51,844
▲ 39% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 93,720.
People and assets in 2025
1.7
Average over the fiscal year, from the social balance sheet.
€ 122,540
▼ 5% vs 2024
€ 72,100 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2025
€ 271,395
▼ 6% vs 2024
€ 17,252 is repaid this year. At this pace the long-term loan is gone in ≈ 16 years.
€ 39,844
▼ 18% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 20,620
▼ 21% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 135,837 | € 151,651 | € 180,455 | € 171,509 | ▼ 5% |
| Profit after taxes | € -10,090 | € -5,925 | € 21,386 | € 19,647 | ▼ 8% |
| Equity | € 120,612 | € 114,687 | € 136,073 | € 155,720 | ▲ 14% |
| Total debts | € 611,007 | € 550,619 | € 399,694 | € 366,703 | ▼ 8% |
| Cash | € 213,540 | € 155,533 | € 37,278 | € 51,844 | ▲ 39% |
| Land & buildings | € 367,292 | € 348,926 | € 330,561 | € 312,196 | ▼ 6% |
| Retained profit | € 58,612 | € 52,687 | € 74,073 | € 93,720 | ▲ 27% |
| Bank debt | € 448,357 | € 430,460 | € 288,503 | € 271,395 | ▼ 6% |
| Balance sheet total | € 731,619 | € 665,306 | € 535,767 | € 522,422 | ▼ 2% |
| Employees (FTE) | 1.5 | 1.5 | 1.7 | 1.7 |
Key figures of APOTEEK VERCAMMEN, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to APOTEEK VERCAMMEN?
What happened at APOTEEK VERCAMMEN in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 19,647 (▼ 8% vs 2024). Source: NBB ↗
- New establishment in Aalst. KBO
- Start of the company according to the CBE. KBO
In short
From € 10,090 loss in 2022 to € 19,647 profit in 2025.
Best year ever: 2024, with € 21,386 profit.
On average € 100,900 of value added per employee in 2025.
Management
The stake of BEMARSO comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
APOTEEK VERCAMMENBehind APOTEEK VERCAMMEN is Bemarso BV. The shares are held by BEMARSO (100%).
Directors
According to the 2025 annual accounts
Shareholders
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Immerzeeldreef 61
9300 Aalst
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0425.132.786
- VAT number
- BE 0425.132.786
- Registered office
- Immerzeeldreef 61, 9300 Aalst
- Names & denominations
- APOTEEK VERCAMMEN
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 23 December 1983
- Peppol
- Active · Active since 25 Jun 2025
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers